| Dr Patrick Paul Branagan, DPM | |
|
3506 W Okmulgee St, Muskogee, OK 74401-5073 | |
| (918) 681-4488 | |
| (918) 681-4499 |
| Full Name | Dr Patrick Paul Branagan |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 14 Years |
| Location | 3506 W Okmulgee St, Muskogee, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669799441 | NPI | - | NPPES |
| H792 | Other | MD | BLUE CROSS |
| E602 | Other | MD | NATIONAL CAP BLUE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213EP1101X | Podiatrist - Primary Podiatric Medicine | 322 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Health Home Health Of Eastern Oklahoma | Muskogee, OK | Home health agency |
| Saint Francis Hospital Muskogee | Muskogee, OK | Hospital |
| Saint Francis Hospital Vinita, Inc | Vinita, OK | Hospital |
| Mcalester Regional Health Center | Mcalester, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Warren Clinic Inc | 8820900293 | 604 |
News Archive
The open enrollment period begins in one week for 2018 marketplace coverage, but many consumers are confused about what to expect. No wonder!
In this country, three subjects that are guaranteed to generate a heated debate are religion, politics and, you guessed it, health insurance. Of the first two, Mark Twain observed that "people's beliefs and convictions are in almost every case gotten at second-hand."
A new science called neurogastronomy explores brain and behavior in the context of food, and the International Society of Neurogastronomy's inaugural symposium will bring together for the first time the "four pillars" of neurogastronomy to share their knowledge and begin a dialogue that they hope will ultimately lead to real changes in brain behavior as it relates to food.
Researchers in the UK and Taiwan have demonstrated the potential of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the virus responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
› Verified 3 days ago
| Provider Name | Warren Clinic Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1174582282 PECOS PAC ID: 8820900293 Enrollment ID: O20031104000252 |
News Archive
The open enrollment period begins in one week for 2018 marketplace coverage, but many consumers are confused about what to expect. No wonder!
In this country, three subjects that are guaranteed to generate a heated debate are religion, politics and, you guessed it, health insurance. Of the first two, Mark Twain observed that "people's beliefs and convictions are in almost every case gotten at second-hand."
A new science called neurogastronomy explores brain and behavior in the context of food, and the International Society of Neurogastronomy's inaugural symposium will bring together for the first time the "four pillars" of neurogastronomy to share their knowledge and begin a dialogue that they hope will ultimately lead to real changes in brain behavior as it relates to food.
Researchers in the UK and Taiwan have demonstrated the potential of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the virus responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patrick Paul Branagan, DPM 6600 S Yale Ave Ste 1400, Tulsa, OK 74136-3331 Ph: (888) 247-0125 | Dr Patrick Paul Branagan, DPM 3506 W Okmulgee St, Muskogee, OK 74401-5073 Ph: (918) 681-4488 |
News Archive
The open enrollment period begins in one week for 2018 marketplace coverage, but many consumers are confused about what to expect. No wonder!
In this country, three subjects that are guaranteed to generate a heated debate are religion, politics and, you guessed it, health insurance. Of the first two, Mark Twain observed that "people's beliefs and convictions are in almost every case gotten at second-hand."
A new science called neurogastronomy explores brain and behavior in the context of food, and the International Society of Neurogastronomy's inaugural symposium will bring together for the first time the "four pillars" of neurogastronomy to share their knowledge and begin a dialogue that they hope will ultimately lead to real changes in brain behavior as it relates to food.
Researchers in the UK and Taiwan have demonstrated the potential of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the virus responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
› Verified 3 days ago
Dr. Larry Hale Pittman Jr., D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3300 Chandler Rd, Suite 105, Muskogee, OK 74403 Phone: 918-681-3333 | |
Practical Podiatry Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 508 Cardinal Rd, Muskogee, OK 74403 Phone: 918-931-1425 | |
Muskogee Foot Clinic Inc. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2400 W Broadway St, Muskogee, OK 74401 Phone: 918-687-5171 Fax: 918-687-7150 | |
Dr. Kevin Richard Dux, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 101 Rockefeller Dr, Suite 204, Muskogee, OK 74401 Phone: 918-681-4488 Fax: 918-681-4499 | |
Muskogee Institute Of Foot And Ankle Surgery Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 101 Rockefeller Dr, Suite 204, Muskogee, OK 74401 Phone: 918-681-4488 Fax: 918-681-4499 | |
Pittman Foot Specialists Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3300 Chandler Rd, Suite 109, Muskogee, OK 74403 Phone: 918-682-3668 Fax: 918-682-4127 |